Human monocyte activation by biologic and biodegradable meshes in vitro.
BACKGROUND
Inflammation and wound healing play critical roles in the integration of biologic and biodegradable meshes (BMs) at hernia repair sites. Monocytes/macrophages (M/MØs) are key cells controlling inflammation and wound healing. These cells release inflammatory cytokines and growth factors such as interleukin (IL)-1beta, IL-6, IL-8, and vascular endothelial growth factor (VEGF) upon activation. Although BMs have been increasingly used in hernia repairs worldwide, to date, investigations of inflammatory responses to various BMs have been limited.


METHODS
Mesh samples of three acellular human dermis-derived biologic meshes (AlloDerm, AlloMax, FlexHD) and one biodegradable synthetic mesh (Bio-A) were placed in 96-well plates. Human peripheral blood mononuclear cells (PBMCs) were isolated from six healthy subjects, added to each well, and incubated for 7 days. Culture supernatants were assayed for IL-1beta, IL-6, IL-8, and VEGF levels using a multiplex bead-base immunoassay system (Bio-Plex).


RESULTS
All four meshes induced cytokine expression from activated M/MØs to varying degrees in vitro. FlexHD induced significantly more IL-1beta (2,591 pg/ml) than AlloMax (517 pg/ml), AlloDerm (48 pg/ml), or Bio-A (28 pg/ml) (p < 0.001). AlloMax stimulated a significantly greater quantity of IL-6 (38,343 pg/ml) than FlexHD (19,317 pg/ml), Bio-A (191 pg/ml), or AlloDerm (103 pg/ml) (p < 0.05). Interleukin-8 and VEGF displayed trends similar to that of IL-6. There were no significant differences in cytokine production between AlloDerm and Bio-A.


CONCLUSIONS
This study demonstrated that human macrophages are activated by human dermis-derived biologic and biodegradable meshes in vitro. A wide range of cytokine and growth factor induction was seen among the different mesh products. These differences in M/MØ activation may be related to the proprietary processing technologies of the studied meshes. The study results raise the possibility that these differences in M/MØ activation could indicate varying intensities of inflammation that control integration of different biologic meshes at the sites of hernia repair.
Orenstein
Sean B
SB
Department of Surgery, Connecticut Comprehensive Center for Hernia Repair, University of Connecticut Health Center, 263 Farmington Avenue-MC 3955, Farmington, CT 06030, USA.
Qiao
Yi
Y
Kaur
Manjot
M
Klueh
Ulrike
U
Kreutzer
Don L
DL
Novitsky
Yuri W
YW
D020341:Absorbable Implants; D000704:Analysis of Variance; D003094:Collagen; D059685:Herniorrhaphy; D006801:Humans; D066298:In Vitro Techniques; D053583:Interleukin-1beta / Q000276:immunology; D015850:Interleukin-6 / Q000276:immunology; D016209:Interleukin-8 / Q000276:immunology; D008262:Macrophage Activation; D009000:Monocytes / Q000276:immunology*; D013526:Surgical Mesh; D042461:Vascular Endothelial Growth Factor A / Q000276:immunology
C582618:FlexHD; D053583:Interleukin-1beta; D015850:Interleukin-6; D016209:Interleukin-8; D042461:Vascular Endothelial Growth Factor A; D003094:Collagen
Am J Surg. 2007 Aug;194(2):192-8
17618803
Lancet. 2003 Nov 8;362(9395):1561-71
14615114
Surg Endosc. 2004 Oct;18(10):1411-9
15791361
Tissue Eng Part A. 2008 Dec;14(12):2021-31
18657025
Semin Immunol. 2008 Apr;20(2):109-16
18083531
J Infect. 2007 Mar;54(3):250-6
16828518
Biomaterials. 2006 Jul;27(19):3675-83
16519932
Surg Innov. 2009 Mar;16(1):26-37
19223383
J Am Coll Surg. 2007 Nov;205(5):654-60
17964441
Mol Biol Cell. 1992 Feb;3(2):211-20
1550962
J Clin Endocrinol Metab. 1999 Nov;84(11):4079-84
10566653
Transpl Immunol. 2004 Apr;12(3-4):367-77
15157928
Cytokine Growth Factor Rev. 1998 Mar;9(1):9-23
9720753
Surg Infect (Larchmt). 2008 Aug;9(4):433-42
18759680
Surg Clin North Am. 2008 Feb;88(1):101-12, ix
18267164
J Immunol. 2005 May 1;174(9):5846-55
15843589
J Biol Chem. 2002 Mar 22;277(12):10445-51
11784713
World J Surg. 2007 Oct;31(10):1966-72; discussion 1973-4, 1975
17661188
Surg Clin North Am. 2003 Oct;83(5):1045-51, v-vi
14533902
J Leukoc Biol. 1994 Mar;55(3):410-22
7509844
Surg Clin North Am. 2008 Feb;88(1):17-26, vii
18267159
Surgery. 2004 Jul;136(1):1-4
15232531
Biomaterials. 2008 Jul;29(21):3091-104
18448164
J Invest Dermatol. 2004 Mar;122(3):631-9
15086545
J Trauma. 2009 Mar;66(3):749-57
19276749
Clin Plast Surg. 2006 Apr;33(2):199-211, v-vi
16638463
Wound Repair Regen. 2008 Sep-Oct;16(5):585-601
19128254
Am J Surg. 2006 Nov;192(5):594-7
17071190
Tissue Eng Part A. 2008 Dec;14(12):2009-19
18593339
Tissue Eng Part A. 2008 Nov;14(11):1835-42
18950271
J Biomed Mater Res A. 2009 Jan;88(1):128-39
18260130
Clin Immunol Immunopathol. 1997 Oct;85(1):16-20
9325064
J Minim Access Surg. 2006 Sep;2(3):144-6
21187985
Biochem J. 2003 Aug 15;374(Pt 1):1-20
12773095
Hernia. 2007 Jun;11(3):279-85
17279319
Br J Surg. 2003 Jan;90(1):114-20
12520586
Nat Rev Immunol. 2005 Dec;5(12):953-64
16322748